Artemisinin inhibits gastric cancer cell proliferation through upregulation of p53

Tumor Biology

Volumn 35, Issue 2, 2014, Pages 1403-1409

  Zhang, Hong Tao ^a   Wang, Yun Long ^b   Zhang, Jie ^c   Zhang, Qin Xian ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b Biotech Research Center   (China)

^c XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Artemisinin; Cell cycle regulators; Gastric cancer; p53

Indexed keywords

ARTEMISININ; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; P21 KIP1 PROTEIN; PROTEIN P21; PROTEIN P27; PROTEIN P53; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CANCER; UPREGULATION;

APOPTOSIS; ARTEMISININS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84898906000     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1193-1     Document Type: Article

References (22)

1. Rugge M, Fassan M, Graham DY. Clinical guidelines: secondary prevention of gastric cancer. Nature Reviews Gastroenterology & Hepatology. 2012;9(3):128-9.
2. Smyth EC, Cunningham D. Gastric cancer in 2012: defining treatment standards and novel insights into disease biology. Nature Reviews Clinical Oncology. 2013;10(2):73-4.
3. Ali R, Mirza Z, Ashraf GM, Kamal MA, Ansari SA, Damanhouri GA, et al. New anticancer agents: recent developments in tumor therapy. Anticancer Research. 2012;32(7):2999-3005.
4. Albini A, Tosetti F, Li VW, Noonan DM, Li WW. Cancer prevention by targeting angiogenesis. Nature Reviews Clinical Oncology. 2012;9(9):498-509.
5. Javeshghani S, Zakikhani M, Austin S, et al. Carbon source and myc expression influence the antiproliferative actions of metformin. Cancer Research. 2012;72(23):6257-67.
6. Zhang X, Gu L, Li J, et al. Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells. Cancer Research. 2010;70(23):9895-904.
7. Kato K, Gong J, Iwama H, et al. The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo. Molecular Cancer Therapeutics. 2012;11(3):549-60.
8. Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR. The anti-malarial artesunate is also active against cancer. International Journal of Oncology. 2001;18(4):767-7739.
9. Utzinger J, Xiao SH, Tanner M, Keiser J. Artemisinins for schistosomiasis and beyond. Current Opinion in Investigational Drugs. 2007;8(2):105-16. (Pubitemid 46438464)
10. Willoughby Sr JA, Sundar SN, Cheung M, et al. Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression. Journal of Biological Chemistry. 2009;284(4):2203-13.
11. Kong R, Jia G, Cheng ZX, et al. Dihydroartemisinin enhances Apo2L/TRAIL-mediated apoptosis in pancreatic cancer cells via ROS-mediated up-regulation of death receptor 5. PLoS One. 2012;7(5):e37222.
12. Roy S, Gu M, Ramasamy K, et al. p21/Cip1 and p27/Kip1 Are essential molecular targets of inositol hexaphosphate for its antitumor efficacy against prostate cancer. Cancer Research. 2009;69(3):1166-73.
13. Akli S, Van Pelt CS, Bui T, et al.Overexpression of the lowmolecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway. Cancer Research. 2007;67(15):7212-22. (Pubitemid 47206549)
14. Yamada Y, Yoshida T, Hayashi K, et al. p53 genemutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases. Cancer Research. 1991;51(21):5800-5.
15. Tin AS, Sundar SN, Tran KQ, et al. Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes. Anti-Cancer Drugs. 2012;23(4):370-9.
16. Xiao F, Gao W, Wang X, Chen T. Amplification activation loop between caspase-8 and -9 dominates artemisinin-induced apoptosis of ASTC-a-1 cells. Apoptosis. 2012;17(6):600-11.
17. Cerezo M, Tichet M, Abbe P, et al. Metformin blocks melanoma invasion and metastasis development in AMPK/p53-dependent manner. Molecular Cancer Therapeutics. 2013;12(8):1605-15.
18. Lee J, van Hummelen P, Go C, et al. High-throughput mutation profiling identifies frequent somatic mutations in advanced gastric adenocarcinoma. PLoS One. 2012;7(6):e38892.
19. Cotter TG. Apoptosis and cancer: the genesis of a research field. Nature Reviews Cancer. 2009;9(7):501-7.
20. Vakifahmetoglu-Norberg H, Kim M, Xia HG, et al. Chaperone-mediated autophagy degrades mutant p53. Genes and Development. 2013;27(15):1718-30.
21. Wang Y, Huang ZQ, Wang CQ, et al. Artemisinin inhibits extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinase-9 expression via a protein kinase Cδ/p38/extracellular signal-regulated kinase pathway in phorbol myristate acetateinduced THP-1 macrophages. Clinical and Experimental Pharmacology and Physiology. 2011;38(1):11-8.
22. Sarina, Yagi Y, Nakano O, et al. Induction of neurite outgrowth in PC12 cells by artemisinin through activation of ERK and p38 MAPK signaling pathways. Brain Research. 2013;1490:61-71.